Andrea Cossu
YOU?
Author Swipe
View article: The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation
The Endoscopic Management of Anastomotic Strictures After Esophagogastric Surgery: A Comprehensive Review of Emerging Approaches Beyond Endoscopic Dilation Open
Anastomotic strictures are a common complication following esophagogastric surgery, with prevalence varying depending on the type of surgery and anatomical site. These strictures can lead to debilitating symptoms such as dysphagia, pain, a…
View article: Endoscopic Management of Post-Esophagectomy Delayed-Gastric-Conduit-Emptying (DGCE): Results from a Cohort Study in a Tertiary Referral Center with Comparison between Procedures
Endoscopic Management of Post-Esophagectomy Delayed-Gastric-Conduit-Emptying (DGCE): Results from a Cohort Study in a Tertiary Referral Center with Comparison between Procedures Open
Delayed Gastric Conduit Emptying (DGCE) occurs in 15-39% of patients who underwent esophagectomy. Intra-Pyloric Injection of Botulinum Toxin (IPBT), Pneumatic Balloon Dilation (PBD), and the same session combination (BTPD), represent the m…
View article: Supplementary Tables from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Supplementary Tables from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma Open
Supplementary Table 1. Clinical characteristics of the EAC patients from the prospective cohort (protocol ESO-CA001) Supplementary Table 2. Clinical characteristics of the EAC patients from the additional retrospective cohort selected for …
View article: Supplementary Materials and methods from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Supplementary Materials and methods from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma Open
Supplementary Materials and methods
View article: Supplementary Tables from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Supplementary Tables from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma Open
Supplementary Table 1. Clinical characteristics of the EAC patients from the prospective cohort (protocol ESO-CA001) Supplementary Table 2. Clinical characteristics of the EAC patients from the additional retrospective cohort selected for …
View article: Supplementary Figures from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Supplementary Figures from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma Open
Supplementary Figures S1 to S14 Supplementary Figure 1. Multidimensional analysis of baseline EAC tumor and blood samples Supplementary Figure 2. Baseline higher immune gene signatures and reduced resistance to stress are associated with r…
View article: Data from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Data from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma Open
Current treatment for patients with locally advanced esophageal adenocarcinoma (EAC) is neoadjuvant chemotherapy (nCT), alone or combined with radiotherapy, before surgery. However, fewer than 30% of treated patients show a pathological co…
View article: Supplementary Figures from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Supplementary Figures from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma Open
Supplementary Figures S1 to S14 Supplementary Figure 1. Multidimensional analysis of baseline EAC tumor and blood samples Supplementary Figure 2. Baseline higher immune gene signatures and reduced resistance to stress are associated with r…
View article: Supplementary Materials and methods from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Supplementary Materials and methods from Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma Open
Supplementary Materials and methods
View article: 630. ENDOSCOPIC MANAGEMENT OF DELAYED-GASTRIC-EMPTYING AFTER ESOPHAGECTOMY IN A TERTIARY REFERRAL CENTER: COMPARISON BETWEEN DIFFERENT ENDOSCOPIC PROCEDURES
630. ENDOSCOPIC MANAGEMENT OF DELAYED-GASTRIC-EMPTYING AFTER ESOPHAGECTOMY IN A TERTIARY REFERRAL CENTER: COMPARISON BETWEEN DIFFERENT ENDOSCOPIC PROCEDURES Open
Background Delayed Gastric Emptying (DGE) after Esophagectomy with a gastric conduit is a complication that occurs in 15-39% of patients. It is associated with short and long-term complications and with a poor quality of life. Intra-Pylori…
View article: 490. THE IMPACT OF ONE-LUNG VENTILATION ON POSTOPERATIVE COMPLICATIONS AFTER IVOR LEWIS ESOPHAGECTOMY
490. THE IMPACT OF ONE-LUNG VENTILATION ON POSTOPERATIVE COMPLICATIONS AFTER IVOR LEWIS ESOPHAGECTOMY Open
Background One of the most common issue after Ivor Lewis esophagectomy are pulmonary complications, affecting up to 27% of patients, leading to longer hospital stay and higher healthcare costs. Traditionally, one-lung ventilation (OLV) wit…
View article: Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study
Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study Open
Background The association between volume, complications and pathological outcomes is still under debate regarding colorectal cancer surgery. The aim of the study was to assess the association between centre volume and severe complications…
View article: Supplementary Materials and methods from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Supplementary Materials and methods from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Supplementary Materials and methods
View article: Supplementary Figures from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Supplementary Figures from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Supplementary Figures S1 to S14 Supplementary Figure 1. Multidimensional analysis of baseline EAC tumor and blood samples Supplementary Figure 2. Baseline higher immune gene signatures and reduced resistance to stress are associated with r…
View article: Supplementary Tables from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Supplementary Tables from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Supplementary Table 1. Clinical characteristics of the EAC patients from the prospective cohort (protocol ESO-CA001) Supplementary Table 2. Clinical characteristics of the EAC patients from the additional retrospective cohort selected for …
View article: Data from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Data from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Current treatment for patients with locally advanced esophageal adenocarcinoma (EAC) is neoadjuvant chemotherapy (nCT), alone or combined with radiotherapy, before surgery. However, fewer than 30% of treated patients show a pathologic comp…
View article: Supplementary Materials and methods from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Supplementary Materials and methods from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Supplementary Materials and methods
View article: Supplementary Figures from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Supplementary Figures from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Supplementary Figures S1 to S14 Supplementary Figure 1. Multidimensional analysis of baseline EAC tumor and blood samples Supplementary Figure 2. Baseline higher immune gene signatures and reduced resistance to stress are associated with r…
View article: Data from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Data from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Current treatment for patients with locally advanced esophageal adenocarcinoma (EAC) is neoadjuvant chemotherapy (nCT), alone or combined with radiotherapy, before surgery. However, fewer than 30% of treated patients show a pathologic comp…
View article: Supplementary Tables from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Supplementary Tables from Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Supplementary Table 1. Clinical characteristics of the EAC patients from the prospective cohort (protocol ESO-CA001) Supplementary Table 2. Clinical characteristics of the EAC patients from the additional retrospective cohort selected for …
View article: Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma Open
Current treatment for patients with locally advanced esophageal adenocarcinoma (EAC) is neoadjuvant chemotherapy (nCT), alone or combined with radiotherapy, before surgery. However, fewer than 30% of treated patients show a pathologic comp…
View article: Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy
Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy Open
Importance Delays in screening programs and the reluctance of patients to seek medical attention because of the outbreak of SARS-CoV-2 could be associated with the risk of more advanced colorectal cancers at diagnosis. Objective To evaluat…
View article: Relaparoscopy in the management of post-operative complications after minimally invasive gastrectomy for gastric cancer
Relaparoscopy in the management of post-operative complications after minimally invasive gastrectomy for gastric cancer Open
Laparoscopy has already been validated for treatment of early gastric cancer. Despite that, no data have been published about the possibility of a minimally invasive approach to surgical complications after primary laparoscopic surgery. In…
View article: Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study
Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study Open
View article: Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe Open
View article: The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017
The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017 Open
Introduction Delirium and sarcopenia are common, although underdiagnosed, geriatric syndromes. Several pathological mechanisms can link delirium and low skeletal muscle mass, but few studies have investigated their association. We aimed to…
View article: Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19
Multi-Drug Resistance Bacterial Infections in Critically Ill Patients Admitted with COVID-19 Open
Introduction. It is known that bacterial infections represent a common complication during viral respiratory tract infections such as influenza, with a concomitant increase in morbidity and mortality. Nevertheless, the prevalence of bacter…
View article: Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis
Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis Open
Background:After the results reported by the “Chemoradiotherapy for esophageal Cancer Followed by Surgery Study” (CROSS) trial, neo-adjuvant chemoradiotherapy became the standard treatment for locally advanced cancers of esophagus and gast…
View article: Diaphragmatic hernia after Ivor Lewis esophagectomy for cancer: a retrospective analysis of risk factors and post-repair outcomes
Diaphragmatic hernia after Ivor Lewis esophagectomy for cancer: a retrospective analysis of risk factors and post-repair outcomes Open
PEDH represents a relevant surgical complication after Ivor Lewis esophagectomy for cancer, including a 5.3% incidence and requiring surgical repair. Pathological complete response and lymph node harvest were found to be independent risk f…
View article: Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot
Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot Open
Coronavirus Disease-19 (COVID-19) outbreak has significantly burdened healthcare systems worldwide, leading to reorganization of healthcare services and reallocation of resources. The Italian Society for Study of Esophageal Diseases (SISME…